Intuitive Surgical - ISRG Stock Forecast, Price & News

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Analysts Set New Price Targets

A number of research firms have recently weighed in on ISRG. BTIG Research cut their price target on Intuitive Surgical from $355.00 to $247.00 and set a "buy" rating on the stock in a report on Monday, July 18th. Raymond James cut their price target on Intuitive Surgical from $294.00 to $255.00 in a report on Friday, July 22nd. Morgan Stanley cut their price target on Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating on the stock in a report on Friday, July 15th. Evercore ISI cut their price target on Intuitive Surgical from $210.00 to $175.00 in a report on Friday, July 22nd. Finally, TheStreet cut Intuitive Surgical from a "b-" rating to a "c+" rating in a report on Thursday, May 19th. Seven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $273.23.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $232.88 on Wednesday. Intuitive Surgical has a twelve month low of $186.83 and a twelve month high of $369.69. The stock has a market cap of $83.16 billion, a price-to-earnings ratio of 59.26, a PEG ratio of 6.70 and a beta of 1.29. The firm's 50 day moving average price is $212.85 and its two-hundred day moving average price is $248.92.

Intuitive Surgical (NASDAQ:ISRG - Get Rating) last posted its quarterly earnings data on Thursday, July 21st. The medical equipment provider reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.13. Intuitive Surgical had a net margin of 24.05% and a return on equity of 12.04%. During the same quarter in the previous year, the business posted $1.42 EPS. On average, research analysts forecast that Intuitive Surgical will post 3.76 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 9,000 shares of the business's stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $225.00, for a total transaction of $2,025,000.00. Following the transaction, the executive vice president now directly owns 217 shares in the company, valued at approximately $48,825. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, EVP Myriam Curet sold 9,000 shares of the business's stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $225.00, for a total transaction of $2,025,000.00. Following the transaction, the executive vice president now directly owns 217 shares in the company, valued at approximately $48,825. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Gary S. Guthart sold 79,412 shares of the business's stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $216.30, for a total transaction of $17,176,815.60. Following the transaction, the chief executive officer now owns 54,607 shares in the company, valued at $11,811,494.10. The disclosure for this sale can be found here. In the last three months, insiders have sold 94,787 shares of company stock worth $20,719,321. Corporate insiders own 0.90% of the company's stock.